Nine Point Two Capital LLC Seagen Inc. Transaction History

Nine Point Two Capital LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$191.51 - $216.16 $17,810 - $20,102	-93 Reduced 7.04%	1,228 $260,000
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $247,872 - $272,456	1,321 New	1,321 $254,000
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $248,472 - $294,622	2,117 New	2,117 $272,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Nine Point Two Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Nine Point Two Capital LLC with notifications on news.